Characterization and whole genome analysis of human papillomavirus type 16 E1-1374∧63nt variants

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Sabol, Ivan ^a   Matovina, Mihaela ^b   Si Mohamed, Ali ^c   Grce, Magdalena ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; PROTEIN E6;

ARTICLE; E1 1374 63NT GENE; FEMALE; GENE DUPLICATION; GENE E1; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOME ANALYSIS; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LIFE CYCLE; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; UTERINE CERVIX CYTOLOGY; VIRUS GENE; VIRUS GENOME; VIRUS TYPING;

AMINO ACID SUBSTITUTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; GENETIC VARIATION; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS, VIRAL; PHYLOGENY; PROTEIN CONFORMATION; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 84864230217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041045     Document Type: Article

References (72)

1. Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-528.
2. Bernard H-U, Calleja-Macias IE, Dunn ST, (2006) Genome variation of human papillomavirus types: Phylogenetic and medical implications. Int J Cancer 118: 1071-1076.
3. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11: 1048-1056 doi:10.1016/S1470-2045(10)70230-8.
4. IARC (2007) Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 90 Human papillomaviruses. Lyon, France: IARC Press. 670 p.
5. Giannoudis A, Herrington CS, (2001) Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193: 295-302.
6. Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, et al. (2003) Distribution of Human Papillomavirus Types 16 and 18 Variants in Squamous Cell Carcinomas and Adenocarcinomas of the Cervix. Cancer Res 63: 7215-7220.
7. Sabol I, Matovina M, Gasperov N, Grce M, (2008) Identification of a Novel Human Papillomavirus Type 16 E1 Gene Variant With Potentially Reduced Oncogenicity. J Med Virol 80: 2134-2140 doi:10.1002/jmv.21304.
8. Bogovac Z, Lunar MM, Kocjan BJ, Seme K, Jančar N, et al. (2011) Prevalence of HPV 16 genomic variant carrying a 63 bp duplicated sequence within the E1 gene in Slovenian women. Acta Dermatovenerol Alp Panonica Adriat 20: 135-139.
9. Milutin-Gašperov N, Sabol I, Halec G, Matovina M, Grce M, (2007) Retrospective study of the prevalence of high-risk human papillomaviruses among Croatian women. Coll Antropol 31: 89-96.
10. Ovanin-Rakić A, Pajtler M, Stanković T, Audy-Jurković S, Ljubojević N, et al. (2003) The classification of cytologic findings of cervix uteri "Zagreb 2002": The Modification of the "Zagreb 1990" and "NCI Bethesda System 2001" Classifications. Gynaecol Perinatol 12: 148-153.
11. Sabol I, Čretnik M, Hadžisejdić I, Si-Mohamed A, Matovina M, et al. (2009) A new approach for the evaluation of the human papillomavirus type 16 variability with high resolution melting analysis. J Virol Methods 162: 142-147 doi:10.1016/j.jviromet.2009.07.029.
12. Ortiz M, Torres M, Munoz L, Fernandez-Garcia E, Canals J, et al. (2006) Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 44: 1428-1434.
13. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, et al. (2004) Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol 42: 3176-3184.
14. Matovina M, Sabol I, Grubisic G, Gasperov N, Grce M, (2009) Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol 113: 120-127 doi:10.1016/j.ygyno.2008.12.004.
15. Bhattacharjee B, Mandal NR, Roy S, Sengupta S, (2008) Characterization of sequence variations within HPV16 isolates among Indian women: Prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis. Virology 377: 143-150.
16. Huertas-Salgado A, Martín-Gámez DC, Moreno P, Murillo R, Bravo MM, et al. (2010) E6 molecular variants of human papillomavirus (HPV) type 16: An updated and unified criterion for clustering and nomenclature. Virology 410: 201-215 doi:10.1016/j.virol.2010.10.039.
17. Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, et al. (2011) Sequence Imputation of HPV16 Genomes for Genetic Association Studies. PLoS ONE 6: e21375 doi:10.1371/journal.pone.0021375.
18. Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, et al. (2011) Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 6: e20183 doi:10.1371/journal.pone.0020183.
19. Burk RD, Chen Z, Harari A, Smith BC, Kocjan BJ, et al. (2011) Classification and nomenclature system for Human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Panonica Adriat 20: 113-123.
20. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol: in press doi:10.1093/molbev/msr121.
21. Karplus K, (2009) SAM-T08, HMM-based protein structure prediction. Nucleic Acids Res 37: W492-W497 doi:10.1093/nar/gkp403.
22. Zhang Y, (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40 doi:10.1186/1471-2105-9-40.
23. Kelley LA, Sternberg MJE, (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protocols 4: 363-371 doi:10.1038/nprot.2009.2.
24. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612 doi:10.1002/jcc.20084.
25. Enemark EJ, Joshua-Tor L, (2006) Mechanism of DNA translocation in a replicative hexameric helicase. Nature 442: 270-275 doi:10.1038/nature04943.
26. Abbate EA, Berger JM, Botchan MR, (2004) The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Gene Dev 18: 1981.
27. Enemark EJ, Chen G, Vaughn DE, Stenlund A, Joshua-Tor L, (2000) Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus. Mol Cell 6: 149-158.
28. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, et al. (1997) Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71: 2463-2472.
29. de Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, et al. (2004) Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 94: 488-494.
30. Brady CS, Duggan-Keen MF, Davidson JA, Varley JM, Stern PL, (1999) Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters. J Gen Virol 80: 3233-3240.
31. Hu X, Pang T, Guo Z, Ponten J, Nister M, (2001) Oncogene lineages of human papillomavirus type 16 E6, E7 and E5 in preinvasive and invasive cervical squamous cell carcinoma. J Pathol 195: 307-311.
32. Lurchachaiwong W, Junyangdikul P, Payungporn S, Chansaenroj J, Sampathanukul P, et al. (2009) Entire genome characterization of human papillomavirus type 16 from infected Thai women with different cytological findings. Virus Genes 39: 30-38 doi:10.1007/s11262-009-0363-0.
33. Nindl I, Rindfleisch K, Lotz B, Schneider A, Dürst M, (1999) Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82: 203-207.
34. Wheeler CM, Yamada T, Hildesheim A, Jenison SA, (1997) Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35: 11-19.
35. Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, et al. (2009) Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer 125: 2609-2613 doi:10.1002/ijc.24706.
36. Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, et al. (2006) Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 15: 820-822.
37. Kämmer C, Tommasino M, Syrjänen S, Delius H, Hebling U, et al. (2002) Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 86: 269-273.
38. Lee K, Magalhaes I, Clavel C, Briolat J, Birembaut P, et al. (2008) Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression. Virus Res 131: 106-110.
39. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M, (1998) Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352: 1441-1442 doi:10.1016/S0140-6736(05)61263-9.
40. Zehbe I, Wilander E, Delius H, Tommasino M, (1998) Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58: 829-833.
41. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyškova I, et al. (2001) Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94: 711-716.
42. Bontkes HJ, Duin M van, Gruijl TD de, Keen MFD, Walboomers JMM, et al. (1998) HPV 16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78: 166-171.
43. van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, et al. (2000) Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81: 317-325.
44. Hu X, Guo Z, Tianyun P, Pontén F, Wilander E, et al. (1999) HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squamous-cell carcinoma from Swedish patients. Int J Cancer 83: 34-37.
45. Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, et al. (2007) Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J Med Virol 79: 1751-1760.
46. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, et al. (2004) Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol 78: 5934-5945.
47. Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, et al. (2009) Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 383: 69-77.
48. Chen Z, Terai M, Fu L, Herrero R, DeSalle R, et al. (2005) Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 79: 7014-7023.
49. Bhattacharjee B, Sengupta S, (2006) HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women. Gynecol Oncol 100: 372-378.
50. Wilson VG, West M, Woytek K, Rangasamy D, (2002) Papillomavirus E1 proteins: form, function, and features. Virus Genes 24: 275-290.
51. Yasugi T, Benson JD, Sakai H, Vidal M, Howley PM, (1997) Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J Virol 71: 891-899.
52. Sverdrup F, Myers G, (1997) The E1 proteins. Human Papillomaviruses 1997: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM: Theoretical Biology and Biophysics. p. III-37- III-53.
53. Lentz MR, Stevens SM Jr, Raynes J, Elkhoury N, (2006) A phosphorylation map of the bovine papillomavirus E1 helicase. Virol J 3: 13 doi:10.1186/1743-422X-3-13.
54. O'Connor M, Chan SY, Bernard HU, (1995) Transcription factor binding sites in the long control region of genital HPVs. Human Papillomaviruses 1995: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM: Theoretical Biology and Biophysics. p pp. III-21-III-40.
55. Hubert WG, (2005) Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol 79: 5914.
56. Bernard H-U, (2002) Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches. Antivir Ther 7: 219-237.
57. Zheng ZM, Baker CC, (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11: 2286-2302.
58. Androphy EJ, Hubbert NL, Schiller JT, Lowy DR, (1987) Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J 6: 989-992.
59. Sreekumar E, Premraj A, Rasool TJ, (2005) Duck (Anas platyrhynchos), Japanese quail (Coturnix coturnix japonica) and other avian interleukin-2 reveals significant conservation of gene organization, promoter elements and functional residues. Int J Immunogenet 32: 355-365 doi:10.1111/j.1744-313X.2005.00538.x.
60. Wisniewska MB, Ameyar-Zazoua M, Bakiri L, Kaminska B, Yaniv M, et al. (2007) Dimer composition and promoter context contribute to functional cooperation between AP-1 and NFAT. J Mol Biol 371: 569-576 doi:10.1016/j.jmb.2007.05.079.
61. Zhao K-N, Chen J, (2011) Codon usage roles in human papillomavirus. Rev Med Virol 21: 397-411 doi:10.1002/rmv.707.
62. Kanodia S, Fahey LM, Kast WM, (2007) Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets 7: 79-89.
63. Zhao KN, Liu WJ, Frazer IH, (2003) Codon usage bias and A+ T content variation in human papillomavirus genomes. Virus Res 98: 95-104.
64. Cid-Arregui A, Juárez V, zur Hausen H, (2003) A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol 77: 4928-4937.
65. Looman A, Laude M, Stahl U, (1991) Influence of the codon following the initiation codon on the expression of the lacZ gene in Saccharomyces cerevisiae. Yeast 7: 157-165.
66. Grünert S, Jackson RJ, (1994) The immediate downstream codon strongly influences the efficiency of utilization of eukaryotic translation initiation codons. EMBO J 13: 3618-3630.
67. Volkova OA, Kochetov AV, (2010) Interrelations between the nucleotide context of human start AUG codon, N-end amino acids of the encoded protein and initiation of translation. J Biomol Struct Dyn 27: 611-618.
68. Sailaja G, Watts RM, Bernard HU, (1999) Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J Gen Virol 80: 1715-1724.
69. Zouridis H, Hatzimanikatis V, (2008) Effects of codon distributions and tRNA competition on protein translation. Biophys J 95: 1018-1033 doi:10.1529/biophysj.107.126128.
70. Chen GF, Inouye M, (1990) Suppression of the negative effect of minor arginine codons on gene expression; preferential usage of minor codons within the first 25 codons of the Escherichia coli genes. Nucleic Acids Res 18: 1465-1473.
71. Stacey SN, Jordan D, Williamson AJ, Brown M, Coote JH, et al. (2000) Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA. J Virol 74: 7284-7297.
72. Fu C, Parker J, (1994) A ribosomal frameshifting error during translation of the argI mRNA of Escherichia coli. Mol Gen Genet 243: 434-441.